Therefore, we suggest that researchers should continue to identify AD-related variants and their corresponding biological activities and explore the regulation of different PLCG2 variants on signal transduction in microglia as part of AD pathophysiology. The gene discussed is PLCG2; the disease is Alzheimer disease.